For the quarter ending 2025-09-30, PLX has $82,264K in assets. $29,356K in debts. $13,647K in cash and cash equivalents.
| Balance Sheets | 2025-09-30 | 2025-06-30 | ||
|---|---|---|---|---|
| Cash and cash equivalents | 13,647 | 17,895 | ||
| Short-term bank deposits | 15,723 | 15,503 | ||
| Accounts receivable | 14,425 | 9,443 | ||
| Other assets | 1,452 | 1,513 | ||
| Inventories | 21,255 | 21,131 | ||
| Total current assets | 66,502 | 65,485 | ||
| Funds in respect of employee rights upon retirement | 549 | 520 | ||
| Property and equipment, net | 4,724 | 4,746 | ||
| Deferred income tax asset | 2,679 | 2,738 | ||
| Operating lease right of use assets | 7,810 | 4,997 | ||
| Total assets | 82,264 | 78,486 | ||
| Trade | 5,375 | 6,689 | ||
| Other | 15,173 | 15,930 | ||
| Operating lease liabilities | 1,397 | 1,472 | ||
| Total current liabilities | 21,945 | 24,091 | ||
| Liability for employee rights upon retirement | 631 | 615 | ||
| Operating lease liabilities | 6,780 | 3,877 | ||
| Total long term liabilities | 7,411 | 4,492 | ||
| Total liabilities | 29,356 | 28,583 | ||
| Stockholders' equity | 52,908 | 49,903 | ||
| Total liabilities and stockholders' equity | 82,264 | 78,486 | ||
Protalix BioTherapeutics, Inc. (PLX)
Protalix BioTherapeutics, Inc. (PLX)